Biotech entity

Walgreens Boots Alliance

Company WBA

Every one of those 2 sits in a single category, pharma. Of the tracked stories, 2 of 2 also mention CVS Health, the most common co-covered peer. Source depth averages 2 original sources per story, versus 4.1 across the same-window beat baseline.

Last mentioned: Jul 25, 2026

Entity pulse

Recent coverage · Walgreens Boots Alliance

2 stories
6 avg impact
0% positive
50% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.

  • 50% neutral
  • 50% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Walgreens Boots Alliance

Every one of those 2 sits in a single category, pharma. Of the tracked stories, 2 of 2 also mention CVS Health, the most common co-covered peer. Source depth averages 2 original sources per story, versus 4.1 across the same-window beat baseline. That works out to roughly 0.1 stories per week across a 134-day span. Their average consequence score of 6 runs below the beat's 6.4 for that window. Walgreens Boots Alliance appears in 2 tracked Biotech stories published from March 14, 2026 through July 25, 2026.

Stories tracked
2
Per week
0.1
Sources per story
2

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 317 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Walgreens Boots Alliance. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Walgreens Boots Alliance 2

Pharma Neutral

Healthcare Divergence: GLP-1 Leaders Dominate Quant Ratings Post-Earnings

Seeking Alpha's post-earnings quant analysis reveals a stark divide in the healthcare sector, with innovation-driven biopharma stocks significantly outperforming retail pharmacy and managed care. The ratings highlight a shift in investor preference toward high-growth obesity and specialty medicine franchises over traditional defensive value plays.

2 sources

Walgreens Boots Alliance is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.